Clinical and molecular heterogeneity in advanced-stage POLE-mutated endometrial carcinoma: a focus on aggressive subsets and co-mutations.

Cavasin N, Kilzie S, Vinci M, Trozzi R, Nero C, Restaino S, Cassani C, Pignata S, Pisano C, Scibilia G, Fruscio R, Mancari R, Favaretto A, Fassan M, Toffolatti L, Gallina G, Fanfani F, Salutari V, Artioli G

Open source

DOI: 10.3389/fonc.2026.1800797
Published: 2026
Container: Frontiers in oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1800797,
  title = {Clinical and molecular heterogeneity in advanced-stage POLE-mutated endometrial carcinoma: a focus on aggressive subsets and co-mutations.},
  author = {Cavasin N and Kilzie S and Vinci M and Trozzi R and Nero C and Restaino S and Cassani C and Pignata S and Pisano C and Scibilia G and Fruscio R and Mancari R and Favaretto A and Fassan M and Toffolatti L and Gallina G and Fanfani F and Salutari V and Artioli G},
  year = {2026},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2026.1800797},
  url = {https://doi.org/10.3389/fonc.2026.1800797}
}

RIS

TY  - JOUR
TI  - Clinical and molecular heterogeneity in advanced-stage POLE-mutated endometrial carcinoma: a focus on aggressive subsets and co-mutations.
AU  - Cavasin N
AU  - Kilzie S
AU  - Vinci M
AU  - Trozzi R
AU  - Nero C
AU  - Restaino S
AU  - Cassani C
AU  - Pignata S
AU  - Pisano C
AU  - Scibilia G
AU  - Fruscio R
AU  - Mancari R
AU  - Favaretto A
AU  - Fassan M
AU  - Toffolatti L
AU  - Gallina G
AU  - Fanfani F
AU  - Salutari V
AU  - Artioli G
PY  - 2026
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2026.1800797
UR  - https://doi.org/10.3389/fonc.2026.1800797
ER  -

APA

N, C., S, K., M, V., R, T., C, N., S, R., C, C., S, P., C, P., G, S., R, F., R, M., A, F., M, F., L, T., G, G., F, F., V, S., & G, A. (2026). Clinical and molecular heterogeneity in advanced-stage POLE-mutated endometrial carcinoma: a focus on aggressive subsets and co-mutations.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1800797

Source records

pubmed · retrieved 2026-09-25T19:08:15.501Z